Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 28, 2010

View Archived Issues

ERASE MI trial finds elinogrel feasible, well tolerated in STEMI patients undergoing PCI

Dainippon Sumitomo's Metgluco granted Japanese manufacturing and marketing approval

Bionomics initiates enrollment in clinical phase I/II trial of BNC-105 in renal cell carcinoma

FDA and Takeda revise Velcade prescribing information for patients with hepatic impairment

Acrux submits NDA to FDA for Axiron in hypogonadism

JCR and Dainippon Sumitomo to terminate comarketing agreement for Growject

Preliminary trial supports use of dextroamphetamine for methamphetamine addiction

Beta-lactam antibiotic ceftriaxone reduces cocaine-seeking behavior in rats

Efficacy and treatment satisfaction of Technosphere Insulin System reported by patients

Harvard College claims WTA biosynthesis inhibitors for Gram-positive bacterial infections

Novartis claims protein kinase D inhibitors for treatment of heart failure

Palatin Technologies and AstraZeneca disclose MC4 receptor agonists for treatment of obesity

Novel antiapoptotic agents described by sanofi-aventis for treatment of neurodegeneration

PRISM Biolab claims beta-catenin inhibitors for cancer therapy

Spectrum terminates development of ozarelix for benign prostate hypertrophy

YM BioSciences cleared by FDA to enroll U.S. patients in ongoing phase II nimotuzumab trials

Juvaris BioTherapeutics receives financing for further development of JVRS-100 adjuvant

Supernus reports results from phase IIa trial of SPN-810 in ADHD

FDA grants orphan drug designation to Graspa for lymphoblastic leukemia

EpiCept receives FDA orphan drug designation for EpiCept NP-1

GenSpera treats first cancer patient in phase I trial of G-202

CHMP adopts positive opinion on marketing of GSK's pandemic influenza vaccine Arepanrix

Geron and University of California to collaborate on developing GRNOPC-1 for AD

Eribis receives investment for novel cardiovascular peptide therapy

Details of phase III study of ferric carboxymaltose in heart failure released

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...